- 21/12/2007 - Completion of Share Purchase Plan
- 13/12/2007 - BIT225 Phase I Human Trial Data Presented at International Meeting
- 23/11/2007 - Shareholder Update
- 20/11/2007 - Biotron Share Purchase Plan
- 16/11/2007 - Biotron Share Purchase Plan - $2.5 Million Underwriting Agreement
- 6/11/2007 - Commercial Ready Grant for Clinical Development of HIV/AIDS Drug
- 30/10/2007 - Appendix 4C - Quarterly Report 30 September 2007
- 5/10/2007 - Results of Annual General Meeting
- 5/10/2007 - Presentation to Annual General Meeting
- 13/09/2007 - Annual Report for year ended 30 June 2007
- 3/09/2007 - Notice of Annual General Meeting
- 16/08/2007 - BIT225 Phase I Clinical Trial Successfully Completed
- 7/08/2007 - Response to ASX query
- 7/08/2007 - BIT225 Highly Synergistic with Current Anti-Hepatitis C Virus Therapies
- 30/07/2007 - Appendix 4C - Quarterly Report 30 June 2007
- 25/07/2007 - HIV Drug Data Presented at International Conference
- 10/07/2007 - Expansion of Biotron Antiviral Program to Hepatitis B Virus and Phase I Trial Update
- 23/04/2007 - Appendix 4C - Quarterly Report 31 March 2007
- 22/03/2007 - Biotron Begins Phase I Clinical Trial of its HIV Drug BIT225
- 26/02/2007 - Appendix 4D - Half Year Report 31 December 2006
- 9/02/2007 - Hepatitis C Virus Program Advanced
- 8/02/2007 - Presentation of Company Activities
- 23/01/2007 - Appendix 4C - Quarterly Report 31 December 2006
- 23/01/2007 - Successful Completion of Preclinical Program for HIV Drug
 |
 |
 |
 |
Latest share price
ASX:BIT
ASX:BIT